skip to main content

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Discovery of CD33 in human cord blood cells may affect design of targeted AML therapies

    This new discovery provides a possible explanation of why some trials that have used CD33 as a potential target for AML therapies have shown specific toxicities expected from a loss of normal stem cells.

    Read More View all notices

  • New discovery answers long-held question about myelodysplastic syndromes

    In a study published in Nature Communications (June 2018), a team led by Dr. Aly Karsan (BC Cancer) suggests that the key to understanding how both bone marrow failure and acute leukemia, two seemingly opposite conditions, can be caused by MDS lays in the loss of two microRNAs (143 and 145), which activates a signalling pathway in marrow blood cells called TGFβ that suppresses the creation of blood stem cells while expanding the number of slightly more mature progenitor cells being created in the bone marrow

    Read More View all notices

  • Co-targeting EphA2/A3 reduces rGBM tumour growth in mice models

    A bi-specific antibody created by a TFRI-funded team has shown great promise in reducing tumour growth in patients with recurrent glioblastoma (rGBM).

    Read More View all notices

  • How do doctors really feel about active surveillance?

    A new study asking health care professionals why many men with low-risk prostate cancer opt for invasive treatments instead of active surveillance reveals need for clearer guidelines and education on this safe management system.

    Read More View all notices


TFRI launches 2018 Terry Fox Run Challenge

The Terry Fox Research Institute (TFRI) is proud to announce the launch the 2018 Terry Fox Run Challenge, a yearly contest that sees our research teams compete against each other to see which can raise more funds for the Terry Fox Foundation. 

Last year, the contest helped raise over $55,000 for cancer research. Our goal is to surpass that amount this year.  

Read more  Register a team

Achieving Terry's Dream Through Research

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.

Back to Top